440 related articles for article (PubMed ID: 16378982)
1. Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy.
Ribeiro RM; Hazenberg MD; Perelson AS; Davenport MP
J Virol; 2006 Jan; 80(2):802-9. PubMed ID: 16378982
[TBL] [Abstract][Full Text] [Related]
2. Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism.
Zhang Y; de Lara C; Worth A; Hegedus A; Laamanen K; Beverley P; Macallan D
PLoS Pathog; 2013; 9(4):e1003310. PubMed ID: 23637601
[TBL] [Abstract][Full Text] [Related]
3. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
[TBL] [Abstract][Full Text] [Related]
4. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
[TBL] [Abstract][Full Text] [Related]
6. Cell turnover and cell tropism in HIV-1 infection.
Davenport MP; Zaunders JJ; Hazenberg MD; Schuitemaker H; van Rij RP
Trends Microbiol; 2002 Jun; 10(6):275-8. PubMed ID: 12088663
[TBL] [Abstract][Full Text] [Related]
7. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
8. High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection.
Fiser AL; Vincent T; Brieu N; Lin YL; Portalès P; Mettling C; Reynes J; Corbeau P
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):529-35. PubMed ID: 20861743
[TBL] [Abstract][Full Text] [Related]
9. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
Grivel JC; Margolis LB
Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.
Surdo M; Balestra E; Saccomandi P; Di Santo F; Montano M; Di Carlo D; Sarmati L; Aquaro S; Andreoni M; Svicher V; Perno CF; Ceccherini-Silberstein F
PLoS One; 2013; 8(7):e68076. PubMed ID: 23874501
[TBL] [Abstract][Full Text] [Related]
11. Enhanced replication of R5 HIV-1 over X4 HIV-1 in CD4(+)CCR5(+)CXCR4(+) T cells.
Roy AM; Schweighardt B; Eckstein LA; Goldsmith MA; McCune JM
J Acquir Immune Defic Syndr; 2005 Nov; 40(3):267-75. PubMed ID: 16249699
[TBL] [Abstract][Full Text] [Related]
12. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
Locher CP; Witt SA; Kassel R; Dowell NL; Fujimura S; Levy JA
J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.
Bader J; Däumer M; Schöni-Affolter F; Böni J; Gorgievski-Hrisoho M; Martinetti G; Thielen A; Klimkait T;
Clin Infect Dis; 2017 Feb; 64(3):295-300. PubMed ID: 27838645
[TBL] [Abstract][Full Text] [Related]
15. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
16. Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection.
Oswald-Richter K; Grill SM; Leelawong M; Tseng M; Kalams SA; Hulgan T; Haas DW; Unutmaz D
PLoS Pathog; 2007 Apr; 3(4):e58. PubMed ID: 17465678
[TBL] [Abstract][Full Text] [Related]
17. Persistence and emergence of X4 virus in HIV infection.
Weinberger AD; Perelson AS
Math Biosci Eng; 2011 Apr; 8(2):605-26. PubMed ID: 21631149
[TBL] [Abstract][Full Text] [Related]
18. A CCR5
Terahara K; Iwabuchi R; Hosokawa M; Nishikawa Y; Takeyama H; Takahashi Y; Tsunetsugu-Yokota Y
BMC Res Notes; 2019 Apr; 12(1):242. PubMed ID: 31036079
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]